Antares Pharma buy melinda
Start price
08.10.17
/
50%
€3.97
Target price
19.12.17
€4.20
Performance (%)
-48.24%
End price
19.12.17
€2.06
Summary
This prediction ended on 19.12.17 with a price of €2.06. The BUY prediction by melinda for Antares Pharma performed very badly with a performance of -48.24%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Antares Pharma | - | - | - | - |
| iShares Core DAX® | 0,61 % | 0,34 % | 12,06 % | 58,10 % |
| iShares Nasdaq 100 | 0,64 % | -3,17 % | 1,74 % | 84,36 % |
| iShares Nikkei 225® | -0,13 % | 8,92 % | 27,39 % | 64,84 % |
| iShares S&P 500 | 0,54 % | -0,70 % | 1,91 % | 58,67 % |
Comments by melinda for this prediction
In the thread Antares Pharma diskutieren
Kaution ANDS angekündigt 17. April 2017. PDUFA Datum 17. Oktober 2017 eine vorrangige Prüfung von 6 Monaten angenommen.
(Vom Mitglied beendet)